NCT07515638Recruiting
Immun4Cure Cohort of Autoimmune Diseases
Prospective Cohort Study of Clinical and Biological Data in Patients With Autoimmune Diseases (Immun4Cure Cohort)
Source: ClinicalTrials.gov · Last updated 30 Jun 2026
Brief summary (registry, in English)
This prospective cohort study aims to constitute a 500-participant database and biobank including 450 adults with systemic autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis) and 50 healthy controls.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 31 Mar 2026
- Start date
- 23 Jun 2026
- Primary completion date
- 23 Jun 2031
- Lead sponsor
- University Hospital, Montpellier
- NCT number
- NCT07515638
What you commit to
- Study type: Observational
- Planned participants: 500
- From 23 Jun 2026 to the primary completion date, 23 Jun 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who have refused or are unable to give informed consent
- Inability to follow the subject during the study period
- Participation in another interventional study that includes an exclusion period that is still ongoing
- Pregnant women
- Not affiliated with a social security scheme
- Patients without a national insurance number
- Persons under judicial protection, guardianship or trusteeship
- Persons deprived of their liberty
Who the study is looking for
- Group 1: RA
- Adults ≥18 years
- Patient followed as part of their MAI in one of the departments participating in the study at UHM
- Confirmed diagnosis according to international criteria :ACR/EULAR 2010
- Group 2: LES
- Adults ≥18 years
- Patient followed as part of their MAI in one of the departments participating in the study at UHM
- Confirmed diagnosis according to international criteria :ACR/EULAR 2019
- Group 3: SSc
- Adults ≥18 years
- Patient followed as part of their MAI in one of the departments participating in the study at UHM
- Confirmed diagnosis according to international criteria :ACR/EULAR 2013
- Group 4: Healthy Controls
- Adults ≥18 years
- No symptoms of autoimmune disease
- No first-degree family history of autoimmune disease
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Montpellier - CIMA Coordinator of this site? Confirm its status | Montpellier | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.